BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11099667)

  • 41. The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system.
    Clapéron A; Hattab C; Armand V; Trottier S; Bertrand O; Ouimet T
    Brain Res; 2007 May; 1147():12-24. PubMed ID: 17379193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A case of McLeod syndrome caused by a nonsense variation c.942G>A in the
    Ying Y; Yu S; Zhang J; He J; Xu X; Hong X; Zhu F
    Front Genet; 2023; 14():1073139. PubMed ID: 36816020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythrocyte morphology in genetic defects of the Rh and Kell blood group systems.
    Taswell HF; Lewis JC; Marsh WL; Wimer BM; Pineda AA; Brzica SM
    Mayo Clin Proc; 1977 Mar; 52(3):157-9. PubMed ID: 402512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic granulomatous disease, the McLeod syndrome, and the Kell blood groups.
    Marsh WL
    Birth Defects Orig Artic Ser; 1978; 14(6A):9-25. PubMed ID: 365264
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification and characterization of a novel XK splice site mutation in a patient with McLeod syndrome.
    Arnaud L; Salachas F; Lucien N; Maisonobe T; Le Pennec PY; Babinet J; Cartron JP
    Transfusion; 2009 Mar; 49(3):479-84. PubMed ID: 19040496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KX null and the Mcleod phenotype.
    Wimer BM
    Arch Intern Med; 1980 Apr; 140(4):581-2. PubMed ID: 7362401
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides.
    Carbonnet F; Hattab C; Collec E; Le van Kim C; Cartron JP; Bertrand O
    Br J Haematol; 1997 Mar; 96(4):857-63. PubMed ID: 9074432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients.
    Khamlichi S; Bailly P; Blanchard D; Goossens D; Cartron JP; Bertrand O
    Eur J Biochem; 1995 Mar; 228(3):931-4. PubMed ID: 7737196
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
    Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
    Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. XK-Associated McLeod Syndrome: Nonhematological Manifestations and Relation to VPS13A Disease.
    Peikert K; Hermann A; Danek A
    Transfus Med Hemother; 2022 Feb; 49(1):4-12. PubMed ID: 35221863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kell and Kx blood group systems.
    Denomme GA
    Immunohematology; 2015; 31(1):14-9. PubMed ID: 26308465
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel).
    Zhu X; Rivera A; Golub MS; Peng J; Sha Q; Wu X; Song X; Kumarathasan P; Ho M; Redman CM; Lee S
    Am J Hematol; 2009 Aug; 84(8):492-8. PubMed ID: 19544475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.
    Kakaiya RM; Whaley A; Howard-Menk C; Rami J; Papari M; Campbell-Lee S; Malecki Z
    Immunohematology; 2010; 26(3):119-23. PubMed ID: 21214298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of cryopreservation on a rare McLeod donor red blood cell concentrate.
    Turner TR; Clarke G; Denomme GA; Skeate R; Acker JP
    Immunohematology; 2021 Jun; 37(2):78-83. PubMed ID: 34170642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Kmod blood group phenotype in a healthy individual.
    Winkler MM; Beattie KM; Cisco SL; Sigmund KE; Johnson CL; Rabin BI; Marsh WL
    Transfusion; 1989 Sep; 29(7):642-5. PubMed ID: 2773032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein.
    Ho M; Chelly J; Carter N; Danek A; Crocker P; Monaco AP
    Cell; 1994 Jun; 77(6):869-80. PubMed ID: 8004674
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two McLeod patients with novel mutations in XK.
    Dubielecka PM; Hwynn N; Sengun C; Lee S; Lomas-Francis C; Singer C; Fernandez HH; Walker RH
    J Neurol Sci; 2011 Jun; 305(1-2):160-4. PubMed ID: 21463873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic and functional analyses describe a novel 730delG mutation in the KEL gene causing K0 phenotype in a Taiwanese blood donor.
    Yang MH; Li L; Kuo YF; Hung YS; Yu LC; Hung CS; Tsai SJ; Lin KS; Chu DC
    Transfus Med; 2011 Oct; 21(5):318-24. PubMed ID: 21707797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The chorea of McLeod syndrome.
    Danek A; Tison F; Rubio J; Oechsner M; Kalckreuth W; Monaco AP
    Mov Disord; 2001 Sep; 16(5):882-9. PubMed ID: 11746618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Four examples of anti-TSEN and three of TSEN-positive erythrocytes.
    Storry JR; Lindsay G; Rolih S; Co A; Rodberg K; Harris T; Reid ME
    Vox Sang; 2000; 79(3):175-9. PubMed ID: 11111237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.